Evento: Innovation in Drug Discovery and Development – i3D 2019  Ocorre dia 14 de maio

Compartilhar :

Innovation in Drug Discovery and Development – i3D 2019
Date: May 14th 2019
Local: Centro de Treinamento do INRAD
http://centrodetreinamentoinrad.hc.fm.usp.br/ 

Chairs:
Raymond F. Schinazi, PhD, DSc
Frances Winship Walters Professor of Pediatrics at Emory and director of the Laboratory of Biochemical Pharmacology. – Emory UniversitySuzane Kioko Ono, MD, Phd
Department of Gastroenterology – University of São Paulo School of Medicine
Division of Clinical Gastroenterology and Hepatology – Hospital das Clínicas FMUSPAIM:
To advance our knowledge of the ongoing drug development processes and opportunities from academia to real world. Focus on academic-industrial partnerships for translation of technologies.

Target audience
This program is designed to meet the educational needs of researchers, post-graduated students and professionals from industry involved in the drug discovery and development in Brazil.

Topics of Discussion

Academia and Industry partnership in drug discovery and development
Start-ups role in drug discovery and development
Drug Discovery – from Brazil to Global experience
Drug Development – Brazil solutions

PRELIMINARY PROGRAM

May 14th 2019.

13:00 – Registration

14 hs – Oppening
Suzane K Ono & Raymond Schinazi

14:10h Suzane K Ono
From Patient to Bench to Patient – The case of HBV

14:30 Academia-pharma partnership for novel drug discovery – The case of CENTD
Presenter: Ana Marisa Chudzinski-Tavassi – Center of Excellence in New Target Discovery (CENTD) coordinator and Director of Innovation at Butantan Institute

14:50 Bionformatic and Drug Discovery – The case of NAIAD Drug Design
Presenter: Ricardo di Lazzaro – Co-founder of technology and biotechnology companies: AppSimples, VR Monkey, LOTAN Agrosciences, MaChiron and NAIAD.

15:10 Brazil-based pharmaceutical company & drug discovery – The case of EMS
Presenter: Dan Salazar – Chief Science Officer, Board of Directors, EMS S/A

15:30 Development of Active Pharmaceutical Ingredients (APIs) for the domestic pharmaceutical industry – The case of Microbiológica
Presenter: Jaime Rabi – Executive Director at Microbiologica, Química e Farmacêutica Ltda

Plenary talk:
15:50 Disruptive Discoveries for HIV, HCV and HBV Infections
Presenter: Raymond Schinazi

16:40 – Round table & discussion – all

17:30 – Closing remarks

Inscrições aqui.

 

284 visualizações

Compartilhar :